Cannabinol (CBN) is a cannabinoid component found in cannabis. Unlike other cannabinoids, CBN is not produced in the growth of the plant but is created from the exterior oxidation of THC. As THC degenerates, it leaves behind CBN molecules with lower psychoactive properties. Several studies investigating CBN’s effects on mice and pigeons (in comparison to THC) have shown the cannabinoid’s relaxing and sedative properties. In conjunction with terpenes, these studies have also shown CBN’s therapeutic value in helping ease pain and inflammation, promote sleep, stimulate appetite, and act an anticonvulsant. Early studies show CBN as another cannabinoid with great medicinal promise, but there is still a lot of research to be done to discover its full potential.
For the time being, the scientific community is at odds in regards to if it can get you “high”. In 1975 a study resulted in CBN producing effects that were mildly psychoactive.  More notably, the study found that CBN had a direct effect on THC and its ability to amply the resulting psychoactive properties. A contradicting yet more recent study from 1985 listed cannabinol as a non-psychoactive cannabinoid. Nevertheless, the sedative properties of cannabinol have been proven. When compared to 10 mg of Diazepam just 5 mg of cannabinol had an equally sedative effect . If you consume a full-spectrum CBD oil, this is great news, the very small amounts of CBN isn’t enough to produce or enhance any psychoactive effects but may very well be what’s helping so many to fall asleep.
The use and study of CBN is still emerging. Taking into consideration the current (yet limited) evidence for CBN as a potential medicine, we should anticipate an increase in studies focusing on its potential therapeutic benefits. Thankfully, the cannabis industry has been listening to the demands of the public and their interest in healthy, non-psychoactive cannabinoids. It won’t be long before more CBN specific products become available to the public.
 NCBI Article
 Karger Article
 Web MD Article